Literature DB >> 12169580

Mechanisms of NOS2 regulation by Rho GTPase signaling in airway epithelial cells.

Nathan C Kraynack1, Deborah A Corey, Heather L Elmer, Thomas J Kelley.   

Abstract

The aberrant dysregulation of the inducible form of nitric oxide synthase (NOS2) is thought to play a role in many inflammatory disorders including cystic fibrosis (CF). The complex regulation of NOS2 expression is the subject of intense investigation, and one intriguing regulatory pathway known to influence NOS2 expression is the Rho GTPase cascade. We examined NOS2 regulation in response to inflammatory cytokines in a human alveolar epithelial cell line treated with inhibitors of different upstream and downstream components of the Rho GTPase pathway to better define potential signaling mechanisms. Statin-mediated 3-hydroxy-3-methylglutaryl-CoA reductase inhibition increased cytokine-dependent activation of the NOS2 promoter, reversible by the addition of geranylgeranyl pyrphosphate. However, inhibition of Rho-associated kinase (ROCK) with Y-27632 resulted in a decrease in NOS2 promoter activity, yet an increase in NOS2 mRNA and protein levels. Our results suggest that prenylation events influence NOS2 promoter activity independently of the Rho GTPase pathway and that Rho GTPase signaling mediated through ROCK suppresses NOS2 production downstream of promoter function at the message and protein level.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169580     DOI: 10.1152/ajplung.00459.2001

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  15 in total

Review 1.  Genetic variation and clinical heterogeneity in cystic fibrosis.

Authors:  Mitchell L Drumm; Assem G Ziady; Pamela B Davis
Journal:  Annu Rev Pathol       Date:  2011-10-17       Impact factor: 23.472

Review 2.  Molecular pathways for intracellular cholesterol accumulation: common pathogenic mechanisms in Niemann-Pick disease Type C and cystic fibrosis.

Authors:  Nicholas L Cianciola; Cathleen R Carlin; Thomas J Kelley
Journal:  Arch Biochem Biophys       Date:  2011-09-05       Impact factor: 4.013

Review 3.  Antibiotic and anti-inflammatory therapies for cystic fibrosis.

Authors:  James F Chmiel; Michael W Konstan; J Stuart Elborn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

Review 4.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

Review 5.  Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling.

Authors:  David Nichols; James Chmiel; Melvin Berger
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 6.  Anti-inflammatory therapies for cystic fibrosis-related lung disease.

Authors:  David P Nichols; Michael W Konstan; James F Chmiel
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

Review 7.  Sputum biomarkers of inflammation in cystic fibrosis lung disease.

Authors:  Scott D Sagel; James F Chmiel; Michael W Konstan
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

8.  Transcriptional and translational regulation of TGF-beta production in response to apoptotic cells.

Authors:  Yi Qun Xiao; Celio G Freire-de-Lima; William P Schiemann; Donna L Bratton; R William Vandivier; Peter M Henson
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

9.  Interferon γ stimulates accumulation of gas phase nitric oxide in differentiated cultures of normal and cystic fibrosis airway epithelial cells.

Authors:  Lawrence E Ostrowski; Daniel Stewart; Milan Hazucha
Journal:  Lung       Date:  2012-06-23       Impact factor: 2.584

10.  Differential effects of simvastatin on IL-13-induced cytokine gene expression in primary mouse tracheal epithelial cells.

Authors:  Amir A Zeki; Phil Thai; Nicholas J Kenyon; Reen Wu
Journal:  Respir Res       Date:  2012-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.